Product and Claim Development

Power your innovation journey

Generate validated, consumer-centric evidence with IQVIA Consumer Health’s advanced clinical trial, RWE and Rx-to-OTC switch capabilities so you can develop the products and uncover claims to drive the next-generation of OTC, food supplement and personal care products.

Product & Claim Development

Solving your consumer health innovation challenges

 

IQVIA Consumer Health uses Connected Intelligence to drive smarter innovation decision making

 

With IQVIA Consumer Health’s suite of R&D and RWE capabilities, we offer a comprehensive approach to innovation, ensuring that our clients have the necessary evidence to successfully bring new, cutting-edge products to market.

Volker Spitzer
Vice President
IQVIA Consumer Health R&D/RWE Services

Clinical and RWE solutions for Consumer Health

IQVIA Consumer Health’s clinical and real-world evidence capabilities are driven by specific Consumer Health knowledge and insights across all categories, so your innovations are backed by compelling, validated evidence.

Our R&D / RWE team supports you from the pre-study phase to provide insights and strategic advice related to innovative methodologies & technologies, so you can access the most appropriate designs for the purpose of a study and apply the most efficient execution method.

In the past 5 years alone, IQVIA Consumer Health has helped consumer companies conduct over 100 studies across the US, EU, APAC, China and LATAM, covering all the key OTC and consumer health categories. Explore below:

RWE

Pioneering real-world evidence approaches

IQVIA Consumer Health’s pioneering evidence generation approach brings together our clinical & real-world evidence capabilities across the OTC, nutrition, personal care and patient care categories. Our capabilities can be tailored to specific evidence and claims to cover a broad range of scientific themes and by applying innovative methodologies and technologies we help you to meet multiple research goals in a cost- and time-efficient manner.

Compelling Claims

Retrospective RWE for breakthrough claims

IQVIA Consumer Health’s unique approach to maximizing the value of existing real-world evidence, provides real-world perspectives in a consumer-friendly format that builds positive consumer sentiment around your brand. By mining consumer-reported outcomes around perceived efficiency, safety, preferences and other data points, we help you unlock new potential for your OTC, nutrition, personal care and patient care brands.

Consumer satisfaction study to boost brands

Bayer Consumer Health and IQVIA Consumer Health in the Philippines used the power of real-world evidence to generate a list of compelling consumer satisfaction claims

Realizing the potential of RWE for OTC

RWE is a fresh way to use existing data to validate OTC product safety and efficacy and to understand when and why consumers purchase and use these products.

Rx-to-OTC Switch
Rx-to-OTC switch services for the next consumer health generation
Utilizing our Connected Intelligence capabilities, we help you bring the next ground-breaking switch to market

The experience you need for switch success

IQVIA Consumer Health brings over 30 years of experience in helping companies expand the OTC medicines space through Rx-to-OTC switch. Our capabilities cover the whole switch journey, from identifying the right candidate, building and executing clinical trial programs, navigating regulatory pathways and bringing your switch to market.

Our team of switch experts offer a comprehensive suite of switch capabilities:

  • Phase I trials (outpatient and exploratory, proof-of-concept)
  • Phase II trials (dose ranging, safety, efficacy)
  • Phase III trials (safety, efficacy)
  • Phase IV trials (long term safety, claims, phase IV commitments, REMS, special populations, quality of life, patient reported outcomes)

Self-Selection Trials (Self-Recognition, Self-Diagnosis, Self-Selection,)

Actual Use Studies (Studies on All comers & Special Populations)

  • Label Design Consultation
  • Label Comprehension Studies for OTC products (Drug Facts Labels)
  • Patient Package Insert, Supplemental Materials Comprehension

With over 35 years in the areas of Rx-to-OTC switch, we are recognized for developing personalized and customized strategies for clients that lead to positive outcomes with regulators

Julie Aker
VP and General Manager

Related solutions

Contact Us